Crystals of hydroxynorephedrine derivative

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S532000, C514S540000, C514S567000, C514S568000, C514S617000, C560S037000, C560S042000, C562S451000, C564S165000

Reexamination Certificate

active

10489343

ABSTRACT:
The present invention provides ethyl (−)-2-[4-[2-[[(1S,2R)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]amino]ethyl]-2,5-dimethylphenoxy]acetate hydrochloride, crystalline forms thereof and pharmaceutical compositions containing them, which have excellent β3-adrenoceptor stimulating effects, therapeutic effects on pollakiuria or urinary incontinence and storage stabilities and are useful as a medicament.

REFERENCES:
patent: 6538152 (2003-03-01), Tanaka et al.
patent: 1095932 (2001-05-01), None
patent: 2000-212137 (2000-08-01), None
patent: 2000-212138 (2000-08-01), None
patent: 2000-212139 (2000-08-01), None
patent: WO 00/02846 (2000-01-01), None
patent: WO 00/02846 (2000-02-01), None

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Crystals of hydroxynorephedrine derivative does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Crystals of hydroxynorephedrine derivative, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Crystals of hydroxynorephedrine derivative will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3797900

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.